ADHD treatment and the risk of substance abuse.
Sircy
Ruth A
RA
Henry Ford Health System, Sterling Heights, Mich., USA.
Stojanoski
Aco
A
D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000188:drug therapy; D001521:Behavior Therapy; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D002648:Child; D015331:Cohort Studies; D004348:Drug Labeling; D019317:Evidence-Based Medicine; D006801:Humans; D015201:Meta-Analysis as Topic; D009722:Nurse Practitioners; D009730:Nursing Assessment; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D011320:Primary Health Care; D018570:Risk Assessment; D012307:Risk Factors; D019966:Substance-Related Disorders / Q000453:epidemiology / Q000209:etiology*
D000697:Central Nervous System Stimulants